A new memberof the quinoxaline group antibiotics has been detected by HPLC-diode-array screening. The main compoundproduced by Streptomyces tendae strain Tii 4031 showed a high degree of similarity in the UV-visible spectral region with echinomycin and their structural similarity was confirmedby structure elucidation using electron tandemmass spectrometry and 2Dnuclear magnetic resonance. Thenewcompound, namedechinoserine, is a non-cyclic form of echinomycin, but it is not a biosynthetic precursor. Echinoserine is less antibiotically active than echinomycin. compound showing a UV spectrum very similar to that of echinomycin3'40, but having a different retention time. Echinomycin is a cyclic depsipeptide with a thioacetal crossbridge, and is characterized by the presence of two quinoxaline-2-carboxylic acid moieties5'6). It is highly active against 619 Gram-positive bacteria, cytotoxic to mammaliancells in culture, and shows significant antitumor activity7~10).
A new memberof the quinoxaline group antibiotics has been detected by HPLC-diode-array screening. The main compoundproduced by Streptomyces tendae strain Tii 4031 showed a high degree of similarity in the UV-visible spectral region with echinomycin and their structural similarity was confirmedby structure elucidation using electron tandemmass spectrometry and 2Dnuclear magnetic resonance. Thenewcompound, namedechinoserine, is a non-cyclic form of echinomycin, but it is not a biosynthetic precursor. Echinoserine is less antibiotically active than echinomycin.
Streptomycetes still represent an inexhaustible source for new secondary metabolites.
However, efficient screening methods are required to detect this pool of new structures. Weuse the HPLC-DAD method as a nontarget screening strategy. Culture filtrates and raw extracts are analyzed by reversed-phase HPLCand diodearray detection (DAD)2), and the UV-visible spectra of the compounds from biological samples are compared with those of reference compounds stored in an UV-visible absorbance spectral library database. An identification of a metabolite is given, when retention time and UV-visible spectrum are identical. The culture filtrate of Streptomyces tendae strain Tii 4031, isolated from a soil sample of Alice Springs (Australia), was screened by this HPLC-DADmethod. We detected an interesting compound showing a UV spectrum very similar to that of echinomycin3'40, but having a different retention time. Echinomycin is a cyclic depsipeptide with a thioacetal crossbridge, and is characterized by the presence of two quinoxaline-2-carboxylic acid moieties5 '6) . It is highly active against 619 Gram-positive bacteria, cytotoxic to mammaliancells in culture, and shows significant antitumor activity7~10).
HPLC-MSanalysis indicated non-identity of the compound with echinomycin, with molecular masses of 1 136 and 1 101 respectively, being found. In this paper we describe taxonomy of the producing strain, fermentation and isolation, as well as characterization, structural determination and biological activity of this new quinoxaline compound,namedechinoserine. Taxonomy Strain Tu 4031 was isolated from a soil sample taken in Alice Springs, Northern Territory, Australia. The presence of LL-diaminopimelic acid in the peptidoglycan, the characteristic pattern of satured iso-and anteiso fatty acids and the formation of chains of spores in the aerial mycelium allows strain Tii 4031 to be assigned to the genus Streptomyces.
Strain Tii 4031 formed chains of spores of the spiral type with 2~5 extended turns mixed with straight, flexous spore chains. The number of spores in a chain was in a range of 10~50. The surface of the spores was smooth as revealed by electron microscopy. The mass colour of mature sporulating aerial mycelium was gray.
The colour of the substrate mycelium changed depending on the culture mediumand the age of the culture from whitish gray over pale orange to dark brown. Melanoid pigments were produced on peptone -yeast extract iron agar (ISP 6 Fermentation and Isolation Streptomyces tendae Tii 4031 was cultivated in a 10-liter stirred tank fermentor. The complex mediumfor the production of echinoserine consisted of mannitol 2% and soybean meal 2% in tap water (pH 7.5). The batch fermentation required an incubation period of 96 hours, whereby the echinoserine production reached a concentration of 40 mg/liter.
The isolation of echinoserine required four steps of purification.
Polystyrene resin chromatography with Amberlite XAD-16 was used to reduce the culture filtrate volume and to enrich the compound. The compoundwas then extracted with 1-butanol and subjected to exclusion chromatography with Sephadex LH 20. Finally, pure echinoserine was obtained after preparative reversedphase HPLC using 10-micron Nucleosil-100 C-18 material with H2O-MeOHgradient elution.
Characterization
Biological raw extracts from Streptomyces tendae Tii 4031 were screened by the HPLC-DAD method and our HPLC-UV-Vis database2). The main compound, echinoserine, showed a high degree of similarity in the UVvisible spectrum to that of the reference compound echinomycin by a match factor of 997. The maximum matching value is 1000 indicating identical spectra14). However, the retention time of echinoserine (7.68 minutes) differed from that of echinomycin (10.32 minutes), thus excluding identity of both compounds.
This suggested that echinoserine belongs to the family of quinomycin antibiotics. The HPLCelution profile of the culture filtrate extract and UV spectrum of echinoserine is shown in Fig. 1 .
Structure of Echinoserine The UV-spectrum showed absorption maxima at 250nm and 320nm and was almost identical to the spectrum of echinomycin. This led to the conclusion that echinoserine and echinomycin contain the same chromophoric group.
The amino acids in the acidic hydrolysate of echinoserine were determined as their iV-trifluoroacetyl/ «-propyl derivative by gas chromatography (GC) on chiral stationary phase Chirasil-Val15). The presence of L-Ala and D-Ser was thus established together with a non-proteinogenic amino acid which was identified as 7V-methyl-valine (7V-Me-Val) derivative by GC mass spectrometry.
The combined use of homonuclear (TOCSY) and heteronuclear (HSQC, HMBC)2D-NMR techniques allowed the detection of all residues which were found in echinomycin. The chromophore moieties were assigned to two quinoxaline-2-carboxylic acid This indicates the exchange of eight protons by deuterium, which is in agreement with the structure shown in Fig. 3 , having four nitrogen bound and foui oxygen bound protons.
The sequential assignment of the amino acids D-Ser and L-Ala was not possible from the NMR data.
Daughter ion spectra of the fragment ions at m/z 444 and 398 showed a signal at m/z 244 (data not shown). This signal corresponds to the TV-terminal fragment quinoxalinyl-Ser produced by cleavage of the peptide bond between the D-Ser and the L-Ala residue. From these results we conclude that echinoserine has a structure similar to echinomycin but with both lactone-bonds hydrolysed as shown in Fig. 3 .
Biological Properties
The biological activity of echinoserine and echinomycin were compared at a concentration of 1 mg/mlby the agar plate diffusion assay. While echinomycin is highly active against Gram-positive and Gram-negative bacteria at this concentration, echinoserine shows only weak activity against a few bacteria grown on chemically defined media as shown in Table 2 . No antibacterial activity was found on complex media. Echinoserine can be considered as a less active analogue of echinomycin.
Discussion
Screening for newstructures from natural sources In addition, we also screened the echinomycinproducer Streptomyces echinatus and, interestingly, echinoserine was detected in relatively high amounts (30mg/ liter) in the culture filtrate. It has not been detected to date, because of its lower antibacterial activity compared to echinomycin. This shows impressively the advantages of the simple but efficient HPLC-DAD screening method.
Experimental

Microorganisms
Strain Tu 403 1 was isolated from a soil sample collected in Alice Springs, Australia, and identified according to Hutter11} and Shirling and Gottlieb12) as a strain of Streptomyces tendae. It is deposited in the culture collection of our institute. The standard strains for testing the biological activity spectrum were obtained from the stock collection of our laboratory, from ATCC, CBS and DSM.
Fermentation
Strain Sfreptomyces tendae Tii 4031 was cultivated in a 10-liter fermentor (Biostat E, Braun Diessel Biotech) using a production mediumconsisting of: mannitol 2% 623 and soybean meal 2% in tap water (pH 7.5). The fermentor was inoculated with 5vol% of shaking cultures grown for 48 hours in the same medium. The fermentation was carried out at 27°C for 96 hours with an aeration rate of0.5 v/v/m and an agitation of300 rpm. The echinoserine production was monitored by reversedphase HPLC.
Isolation
Hyflo Super-eel (2%) was added to the fermentation broth which was separated by multiple sheet filtration into culture filtrate and myceliumcake. The culture filtrate was passed through an Amberlite XAD-16 column. Impurities were washed out with H2O-MeOH (40 : 60) and echinoserine was desorbed with MeOH.
After removing the organic solvent by evaporation in vacuo, the aqueous residue was adjusted to pH 4 and extracted with 1-butanol. After concentration of the organic extract to dryness, the residue was dissolved in a small amount of MeOHand purified on a Sephadex LH20 column using methanol as eluent. The echinoserine containing fractions were combined and concentrated to dryness.
Pure echinoserine was obtained by preparative reversed-phase HPLC using a stainless steel column (250 x 16mm) filled with 10/mi Nucleosil-100 C-18, and linear gradient elution with H2O -MeOH, starting from 50% MeOHto 80% MeOHwithin 15 minutes and a flow rate of 20 ml/minute. The preparative HPLCsystem consisted of two high-pressure pumps (Sepapress HPP-200/100, Kronwald), gradient unit (Sepacon GCU-3 1 1), and Yalco preparative injection valve (6UW; VICI) with 5 ml sample loop. The UVabsorbance of the eluate was monitored simultaneously at 240nmby a Gilson spectrophotometer Mod. 1 16 equipped with a preparative cell.
Biological Assay Antimicrobial activity was tested by agar plate diffusion assay. 10/A of the test solution in a concentration of lmg/ml were applied onto filter discs (6mm diameter), and the test plates were incubated for 24 hours at 37°C and 27°C, respectively. Echinoserine was dissolved in methanol -0. 1 % aqueous formic acid (1 mg/ml). Electrospray mass spectra were recorded on a triple-quadrupole mass spectrometer API III equipped with a nebulizer-assisted electrospray (ionspray) source1 7) (Sciex, Thornhill, Ontario, Canada). The solution was continuously infused with a medical infusion pump (Modell 22, Harvard Apparatus, Southnatick, U.S.A.) at a flow rate of 5 //1/minute. Positive ion ESI-mass spectra were acquired with a step size of 0.1 u and 0.5u respectively, and a dwell time of 0.5 or 1 msecond. The potential of the spray was held at 4.9 kV. The spectra were recorded with an orifice voltage of + 50V or + 60V. Tandem mass spectra were performed using argon as collision gas with a target gas thickness of about 1.6 x 1014 atoms/cm2 and a collision energy of 30eV. By applying an orifice voltage of + 100V, fragmentation of the molecular ion in the transport region of the source was obtained. The MS-MSspectra of these fragment ions were measured with a target gas thickness of about 6 x 1014 atoms/cm2 and a collision energy of 80eV. Cesium iodide was used for calibration of both quadrupoles. For HPLC-MS a setup as previously described was used18).
NMR Spectroscopy High-resolution NMR spectra were recorded at 305 K on a Bruker AMX600 spectrometer (Bruker Physics, Karlsruhe, Germany) using a selective proton probe for TOCSY19) and an inverse triple resonance probe for HSQC20) and HMBC21). A 5mmol solution of echinoserine in [2H]4-MeOH was used for all measurements. JULY 1995 Pulsed field gradients were applied in HSQCand HMBC for coherence selection and solvent suppression22). In the TOCSY, the OHresonance of the solvent was suppressed by presaturation.
TOCSYand HSQCwere acquired in phase-sensitive absorption mode with quadrature detection in both dimensions using the TPPI method.
Generally 512 experiments with 32 to 128 scans and a data size of 2Kcomplex points were collected for each two-dimensional experiment. For the TOCSY experiment the clean TOCSYpulse sequence23) with a mixing time of64 msecondswas used. The HMBC was optimized for /= 8 Hz. A low pass x/-filter was implemented in the pulse sequence to suppress one-bond correlations. Data processing consisted ofzerofilling to 4 K (F2) and to 1 K in the Fl dimension and apodisation with a shifted squared sine-bell weighting function.
